CD4 and colorectal cancer: On a cell-to-cell basis highly purified CD4+CD25high Treg cells from colorectal cancer patients (before initiation of therapy) showed an equally strong inhibitory function on conventional CD4+CD25− T-cell proliferation (dark grey bar, Fig. 3C, p<0.001).